Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anedol-SP
- Development stage
- Unknown
- Lead developer
- Rosette Pharmaceuticals
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Anedol-SP is a multi-action fixed-dose combination analgesic and anti-inflammatory tablet marketed by MetaneX Life Science. It typically contains three active ingredients: aceclofenac, paracetamol (acetaminophen), and serratiopeptidase. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that preferentially inhibits cyclooxygenase-2 (COX-2) to reduce the production of prostaglandins involved in pain and inflammation. Paracetamol acts as an analgesic and antipyretic, likely through central nervous system mechanisms and weak inhibition of prostaglandin synthesis. Serratiopeptidase is a proteolytic enzyme that helps reduce inflammation and edema by breaking down fibrin and other proteins at the site of injury, thereby improving tissue repair. This combination is widely used for the management of pain and swelling associated with bone and joint disorders like rheumatoid arthritis and osteoarthritis, as well as post-operative inflammation.
- Brand names
- Anedol-SP
- Other names
- Aceclofenac + Paracetamol + Serratiopeptidase
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Anedol-SP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anedol-SP.